RankingsPricing
  1. JP-listed companies
  2. ASKA Pharmaceutical Holdings CO., Ltd.

ASKA Pharmaceutical Holdings CO., Ltd.JP:4886

Market cap
¥67B
P/E ratio
27.2x
Back to summarized table
Income statementBalance sheetCash flow
Mar 31,
2021		Mar 31,
2022		Mar 31,
2023		Mar 31,
2024
Cash and deposits-12,10314,50513,738
Accounts receivable - trade-14,48215,21715,579
Other-2,9112,9482,922
Securities-5,0003,4003,500
Current assets-49,55753,75956,143
Merchandise and finished goods-10,01610,81512,578
Work in process-457429466
Raw materials and supplies-4,5876,4437,358
Other-2,9112,9482,922
Current assets-49,55753,75956,143
Buildings and structures-9,8729,94910,005
Accumulated depreciation--5,311-5,568-5,813
Buildings and structures, net-4,5604,3814,192
Machinery, equipment and vehicles-17,47817,61215,488
Accumulated depreciation--15,746-16,266-14,248
Machinery, equipment and vehicles, net-1,7321,3461,240
Land-4,2494,2494,249
Construction in progress--3891,101
Other-3,5814,0263,762
Accumulated depreciation--3,187-3,208-3,283
Other-393818479
Property, plant and equipment-10,93610,79611,263
Distributorship-5,3663,6732,110
Other-816791766
Other-816791766
Intangible assets-6,1834,4652,877
Intangible assets-6,1834,4652,877
Distributorship-5,3663,6732,110
Other-816791766
Other-816791766
Intangible assets-6,1834,4652,877
Intangible assets-6,1834,4652,877
Investment securities-12,22314,38515,654
Deferred tax assets-2,3761,7172,696
Shares of subsidiaries and associates--40,31940,319
Other-2,0372,0312,127
Deferred tax assets-2,3761,7172,696
Allowance for doubtful accounts--17-17-17
Investments and other assets-16,62018,11720,461
Investments and other assets-16,62018,11720,461
Investment securities-12,22314,38515,654
Deferred tax assets-2,3761,7172,696
Shares of subsidiaries and associates--40,31940,319
Other-2,0372,0312,127
Deferred tax assets-2,3761,7172,696
Allowance for doubtful accounts--17-17-17
Investments and other assets-16,62018,11720,461
Investments and other assets-16,62018,11720,461
Non-current assets-33,73933,37834,601
Non-current assets-33,73933,37834,601
Assets-83,29787,13890,745
Accounts payable - trade-3,1182,8384,060
Short-term borrowings-300300300
Electronically recorded obligations - operating-3,7233,0223,295
Current portion of long-term borrowings-1,4233,1384,680
Short-term borrowings-300300300
Accounts payable - other-4,8674,9475,794
Current portion of long-term borrowings-1,4233,1384,680
Income taxes payable--7362,896
Accounts payable - other-4,8674,9475,794
Provision for bonuses-1,1601,1421,151
Income taxes payable--7362,896
Other-1,3892,2351,715
Current liabilities-16,01117,65023,968
Provision for bonuses-1,1601,1421,151
Provision for bonuses for directors (and other officers)-282474
Other-1,3892,2351,715
Current liabilities-16,01117,65023,968
Liabilities-34,40432,60428,815
Long-term borrowings-12,3239,1854,505
Retirement benefit liability-5,7305,433-
Other-338335341
Non-current liabilities-18,39314,9544,846
Liabilities-34,40432,60428,815
Share capital-1,1971,1971,197
Legal capital surplus--844844
Other capital surplus--41,22041,220
Capital surplus-1,8671,8471,848
Capital surplus-1,8671,8471,848
Retained earnings-45,83349,61956,372
Other retained earnings--8862,559
Retained earnings brought forward--8862,559
Treasury shares--3,479-3,350-3,287
Retained earnings-45,83349,61956,372
Shareholders' equity-45,41949,31556,130
Treasury shares--3,479-3,350-3,287
Shareholders' equity-45,41949,31556,130
Net assets44,51048,89254,53361,930
Valuation difference on available-for-sale securities-3,2314,5904,790
Foreign currency translation adjustment-164405424
Remeasurements of defined benefit plans-77222584
Valuation and translation adjustments-3,4735,2185,799
Net assets44,51048,89254,53361,930
Liabilities and net assets-83,29787,13890,745